Literature DB >> 19107537

Monitoring kidney and renal cyst volumes applying MR approaches on a rapamycin treated mouse model of ADPKD.

Wilfried Reichardt1, Daniel Romaker, Anne Becker, Martin Buechert, Gerd Walz, Dominik von Elverfeldt.   

Abstract

OBJECT: The aim of our study was to determine total cystic volume in a mouse model of PKD using MR imaging to monitor therapeutic effects in vivo.
MATERIALS AND METHODS: We imaged eight female pcy-mice in two groups: four belonged to an untreated control group and four were treated with the anticystic agent rapamycin, which has proven to be effective in reducing cystogenesis in animal models. The mice were imaged using a 9.4 Tesla animal scanner. MRI measurements were taken at six time points during the therapy. Total renal volumes and total cyst volumes were calculated using a thresholding approach.
RESULTS: During the course of the treatment, the total cyst volume increased significantly faster than the total renal volume in the untreated group, indicating that growth of the total renal volume in the untreated group was primarily due to the growth of the cysts, rather than the parenchyma. The measured total renal volume in the control (placebo) group was significantly higher than the volume in the treated group.
CONCLUSION: Using MRI, we were able to monitor the cystic volume in a mouse model of PKD to assess the therapeutic effect of anticystic treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19107537     DOI: 10.1007/s10334-008-0158-7

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  25 in total

1.  Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.

Authors:  Young Rae Lee; Kyu-Beck Lee
Journal:  Nephron Clin Pract       Date:  2006-04-24

2.  CRISP: opening a new frontier in the diagnosis and treatment of PKD.

Authors:  Jared J Grantham
Journal:  Nephrol News Issues       Date:  2006-08

3.  Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease.

Authors:  Yanping Sun; Jing Zhou; Cherie Stayner; Jeeva Munasinghe; Xiaohua Shen; David R Beier; Mitchell S Albert
Journal:  Comp Med       Date:  2002-10       Impact factor: 0.982

Review 4.  The genetics and physiology of polycystic kidney disease.

Authors:  J P Calvet; J J Grantham
Journal:  Semin Nephrol       Date:  2001-03       Impact factor: 5.299

5.  Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned.

Authors:  Dale R Broome; Mark S Girguis; Pedro W Baron; Alfred C Cottrell; Ingrid Kjellin; Gerald A Kirk
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

6.  Micro-MRI methods to detect renal cysts in mice.

Authors:  Hisataka Kobayashi; Satomi Kawamoto; Martin W Brechbiel; Sang-Kyung Jo; Xuzhen Hu; Tianxin Yang; Bhalchandra A Diwan; Thomas A Waldmann; Jurgen Schnermann; Peter L Choyke; Robert A Star
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis.

Authors:  Heike Olbrich; Manfred Fliegauf; Julia Hoefele; Andreas Kispert; Edgar Otto; Andreas Volz; Matthias T Wolf; Gürsel Sasmaz; Ute Trauer; Richard Reinhardt; Ralf Sudbrak; Corinne Antignac; Norbert Gretz; Gerd Walz; Bernhard Schermer; Thomas Benzing; Friedhelm Hildebrandt; Heymut Omran
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

Review 8.  Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.

Authors:  Amy S Peak; Amy Sheller
Journal:  Ann Pharmacother       Date:  2007-08-07       Impact factor: 3.154

9.  A new mouse model of genetically transmitted polycystic kidney disease.

Authors:  H Takahashi; Y Ueyama; T Hibino; Y Kuwahara; S Suzuki; K Hioki; N Tamaoki
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

10.  Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging.

Authors:  D P Wallace; Y-P Hou; Z L Huang; E Nivens; L Savinkova; T Yamaguchi; M Bilgen
Journal:  Kidney Int       Date:  2008-01-09       Impact factor: 10.612

View more
  10 in total

1.  Change in renal parenchymal volume in living kidney transplant donors.

Authors:  Turun Song; Lei Fu; Zixing Huang; Shaofeng He; Ruining Zhao; Tao Lin; Qiang Wei
Journal:  Int Urol Nephrol       Date:  2013-11-01       Impact factor: 2.370

2.  Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD).

Authors:  Anna S Nikonova; Alexander Y Deneka; Anna A Kiseleva; Vladislav Korobeynikov; Anna Gaponova; Ilya G Serebriiskii; Meghan C Kopp; Harvey H Hensley; Tamina N Seeger-Nukpezah; Stefan Somlo; David A Proia; Erica A Golemis
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

3.  4D MRI of polycystic kidneys from rapamycin-treated Glis3-deficient mice.

Authors:  Luke Xie; Yi Qi; Ergys Subashi; Grace Liao; Laura Miller-DeGraff; Anton M Jetten; G Allan Johnson
Journal:  NMR Biomed       Date:  2015-03-23       Impact factor: 4.044

4.  Volumetric analysis of MRI data monitoring the treatment of polycystic kidney disease in a mouse model.

Authors:  Stathis Hadjidemetriou; Wilfried Reichardt; Juergen Hennig; Martin Buechert; Dominik von Elverfeldt
Journal:  MAGMA       Date:  2011-01-07       Impact factor: 2.310

Review 5.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

6.  Automated total kidney volume measurements in pre-clinical magnetic resonance imaging for resourcing imaging data, annotations, and source code.

Authors:  Marie E Edwards; Sigapriya Periyanan; Deema Anaam; Adriana V Gregory; Timothy L Kline
Journal:  Kidney Int       Date:  2020-08-20       Impact factor: 10.612

7.  Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease.

Authors:  Michelle H T Ta; Padmashree Rao; Mayuresh Korgaonkar; Sheryl F Foster; Anthony Peduto; David C H Harris; Gopala K Rangan
Journal:  Physiol Rep       Date:  2014-12-11

8.  Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.

Authors:  Alexander Y Deneka; Leora Haber; Meghan C Kopp; Anna V Gaponova; Anna S Nikonova; Erica A Golemis
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

9.  Magnetic resonance microscopy of renal and biliary abnormalities in excised tissues from a mouse model of autosomal recessive polycystic kidney disease.

Authors:  Choong H Lee; Amber K O'Connor; Chaozhe Yang; Joshua M Tate; Trenton R Schoeb; Jeremy J Flint; Stephen J Blackband; Lisa M Guay-Woodford
Journal:  Physiol Rep       Date:  2015-08

10.  Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Anna S Nikonova; Alexander Y Deneka; Louisa Eckman; Meghan C Kopp; Harvey H Hensley; Brian L Egleston; Erica A Golemis
Journal:  Front Oncol       Date:  2015-10-16       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.